Streetbeat News

Revenues

LNTH

Lantheus Holdings has planned to sell RELISTOR royalties to HealthCare Royalty for an initial payment of $98 million. Lantheus also has the right to receive an additional $5 million if worldwide net sales of RELISTOR in 2025 exceed a specified threshold.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:05 pm

THRY

Thryv Holdings has updated its Q3 revenue forecast to be between $180.5M and $185.0M, compared to the estimated $182.3M. The company also revised its FY23 revenue projection to range from $911M to $923M, up from the previous forecast of $910M-$912M, against an estimate of $916.25M.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:05 pm

DNB

Dun & Bradstreet has revised its FY23 revenue estimates to $2.28B - $2.32B, up from the previous estimate of $2.26B to $2.3B. This is slightly below the consensus estimate of $2.29B. The company expects organic growth of 3.0% to 4.5%.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:04 pm

PGTI

PGT Innovations has projected its Q3 revenue to be between $385M and $405M, which is in line with the estimated $386M.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:04 pm

SOTK

Sono-Tek Corporation (NASDAQ:SOTK) has received a $2.19 million order from an existing clean energy customer, marking the largest order in the company's history. The order is for three production scale systems and is expected to be shipped in the first half of fiscal 2025. This follows an earlier order for one production scale system due to ship in the current fiscal year. The company expects additional orders from this customer and sees potential benefits from higher average selling prices for these systems.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 1:03 pm

CARS

Cars.com has projected its Q3 revenue to be between $172M and $174M, which is higher than the estimated $171.56M.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:03 pm

GCI

Gannett Co has reiterated its FY23 revenue forecast of $2.75B-$2.80B, which is higher than the estimated $2.49B.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:02 pm

SHC

Sotera Health has revised its FY23 revenue guidance to $1.035B-$1.055B, down from the previous guidance of $1.055B-$1.090B. However, the company reaffirmed its adjusted EPS of $0.78-$0.86. The consensus estimates were $1.07B for revenue and $0.80 for EPS.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:02 pm

BCRX

BioCryst Pharmaceuticals expects its FY23 revenue from Orladeyo to be no less than $320M, with operating expenses expected to remain flat to 2022 at approximately $375M. The company anticipates reductions in R&D spending in 2023 due to the discontinuation of the BCX9930 and BCX9250 programs in 2022 and the delay in the BCX10013 clinical program. However, this will be offset by increases in SG&A to support the U.S. launch and global expansion of Orladeyo.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:00 pm

WBD

Warner Bros. Discovery has announced that the ongoing WGA strike will impact its cash provided by operating activities by approximately $100 million.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:59 pm